0001950047-25-006319.txt : 20250825 0001950047-25-006319.hdr.sgml : 20250825 20250825160526 ACCESSION NUMBER: 0001950047-25-006319 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250825 DATE AS OF CHANGE: 20250825 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 251250886 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Nusse Roeland CENTRAL INDEX KEY: 0001492695 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 473 TENNESSEE CITY: PALO ALTO STATE: CA ZIP: 94306 144 1 primary_doc.xml 144 0001492695 XXXXXXXX LIVE 0000842023 BIO-TECHNE CORPORATION 000-17272 614 McKinley Place N.E. Minneapolis MN 55413 612-379-8854 ROELAND NUSSE Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

17040 960388.03 155549587 08/25/2025 NASDAQ Common 08/25/2025 Stock Option Exercise Issuer N 17040 08/25/2025 Cash Y 08/25/2025 /s/ Roeland Nusse